Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidism. Our primary object is to assess the efficacy of the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tomaschitz, Andreas, Fahrleitner-Pammer, Astrid, Pieske, Burkert, Verheyen, Nicolas, Amrein, Karin, Ritz, Eberhard, Kienreich, Katharina, Horina, Jörg H, Schmidt, Albrecht, Kraigher-Krainer, Elisabeth, Colantonio, Caterina, Meinitzer, Andreas, Pilz, Stefan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515510/
https://ncbi.nlm.nih.gov/pubmed/22974443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-12-19
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia